{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T23:57:49Z","timestamp":1740182269572,"version":"3.37.3"},"reference-count":5,"publisher":"American Association for Cancer Research (AACR)","issue":"2","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:sec>\n                  <jats:title>Summary:<\/jats:title>\n                  <jats:p>In ancient Greek mythology, sirens were creatures of stunning beauty whose mystical songs led sailors to sail their boats onto hidden rocks and into total destruction. In this issue, Mason-Osann and colleagues present data in the context of acute myelogenous leukemia to suggest that while synergy may show initial attractions in drug combinations, it may carry with it hazards previously unforeseen.<\/jats:p>\n                  <jats:p>See related article by Mason-Osann et al., p. 95 (1).<\/jats:p>\n               <\/jats:sec>","DOI":"10.1158\/2643-3230.bcd-24-0004","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T01:01:56Z","timestamp":1707440516000},"page":"81-82","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Siren Song of Synergy"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2438-4526","authenticated-orcid":false,"given":"Patrick D.","family":"Bhola","sequence":"first","affiliation":[{"name":"1Dana Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1993-9013","authenticated-orcid":false,"given":"Anthony","family":"Letai","sequence":"additional","affiliation":[{"name":"1Dana Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2024,2,8]]},"reference":[{"key":"2024030421290886900_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1158\/2643-3230.BCD-23-0067","article-title":"Synergistic drug combinations promote the development of resistance in acute myeloid leukemia","volume":"5","author":"Mason-Osann","year":"2024","journal-title":"Blood Cancer Discov"},{"key":"2024030421290886900_bib2","doi-asserted-by":"crossref","first-page":"e50036","DOI":"10.7554\/eLife.50036","article-title":"A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity","volume":"8","author":"Palmer","year":"2019","journal-title":"eLife"},{"key":"2024030421290886900_bib3","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.cell.2017.11.009","article-title":"Combination cancer therapy can confer benefit via patient-to-patient variability without drug additivity or synergy","volume":"171","author":"Palmer","year":"2017","journal-title":"Cell"},{"key":"2024030421290886900_bib4","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1158\/2159-8290.CD-21-0212","article-title":"Independent drug action in combination therapy: implications for precision oncology","volume":"12","author":"Plana","year":"2022","journal-title":"Cancer Discov"},{"key":"2024030421290886900_bib5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1158\/1078-0432.CCR-21-2275","article-title":"Predictable clinical benefits without evidence of synergy in trials of combination therapies with immune-checkpoint inhibitors","volume":"28","author":"Palmer","year":"2022","journal-title":"Clin Cancer Res"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-24-0004\/3413759\/bcd-24-0004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/5\/2\/81\/3421158\/81.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/5\/2\/81\/3421158\/81.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T21:29:21Z","timestamp":1709587761000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/5\/2\/81\/734865\/The-Siren-Song-of-Synergy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,8]]},"references-count":5,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,8]]},"published-print":{"date-parts":[[2024,3,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-24-0004","relation":{},"ISSN":["2643-3230","2643-3249"],"issn-type":[{"type":"print","value":"2643-3230"},{"type":"electronic","value":"2643-3249"}],"subject":[],"published":{"date-parts":[[2024,2,8]]}}}